<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37615336</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1949-0984</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Gut microbes</Title><ISOAbbreviation>Gut Microbes</ISOAbbreviation></Journal><ArticleTitle>Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study.</ArticleTitle><Pagination><StartPage>2247053</StartPage><MedlinePgn>2247053</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2247053</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/19490976.2023.2247053</ELocationID><Abstract><AbstractText>This study is to investigate whether dietary fiber intake prevents vascular and renal damage in a genetic mouse model of systemic lupus erythematosus (SLE), and the contribution of gut microbiota in the protective effects. Female NZBWF1 (SLE) mice were treated with resistant-starch (RS) or inulin-type fructans (ITF). In addition, inoculation of fecal microbiota from these experimental groups to recipient normotensive female C57Bl/6J germ-free (GF) mice was performed. Both fiber treatments, especially RS, prevented the development of hypertension, renal injury, improved the aortic relaxation induced by acetylcholine, and the vascular oxidative stress. RS and ITF treatments increased the proportion of acetate- and butyrate-producing bacteria, respectively, improved colonic inflammation and integrity, endotoxemia, and decreased helper T (Th)17 proportion in mesenteric lymph nodes (MLNs), blood, and aorta in SLE mice. However, disease activity (splenomegaly and anti-ds-DNA) was unaffected by both fibers. T cell priming and Th17 differentiation in MLNs and increased Th17 infiltration was linked to aortic endothelial dysfunction and hypertension after inoculation of fecal microbiota from SLE mice to GF mice, without changes in proteinuria and autoimmunity. All these effects were lower in GF mice after fecal inoculation from fiber-treated SLE mice. In conclusion, these findings support that fiber consumption prevented the development of hypertension by rebalancing of dysfunctional gut-immune system-vascular wall axis in SLE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mole&#xf3;n</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biosanitaria de Granada, ibs.GRANADA, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Correa</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biosanitaria de Granada, ibs.GRANADA, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robles-Vera</LastName><ForeName>I&#xf1;aki</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mi&#xf1;ano</LastName><ForeName>Sof&#xed;a</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Visitaci&#xf3;n</LastName><ForeName>N&#xe9;stor</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barranco</LastName><ForeName>Antonio Manuel</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biosanitaria de Granada, ibs.GRANADA, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n-Morales</LastName><ForeName>Natividad</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pathology, School of Medicine, Instituto de Biopatolog&#xed;a y Medicina Regenerativa (IBIMER) University of Granada, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Valle</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pathology, School of Medicine, Instituto de Biopatolog&#xed;a y Medicina Regenerativa (IBIMER) University of Granada, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ciber de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayo-Mart&#xed;nez</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Metabolomics and Bioanalysis (CEMBIO), Faculty of Pharmacy, Universidad San Pablo CEU, CEU Universities. Campus Monteprincipe, Boadilla del Monte, San Pablo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a</LastName><ForeName>Antonia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Metabolomics and Bioanalysis (CEMBIO), Faculty of Pharmacy, Universidad San Pablo CEU, CEU Universities. Campus Monteprincipe, Boadilla del Monte, San Pablo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toral</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biosanitaria de Granada, ibs.GRANADA, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ciber de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biosanitaria de Granada, ibs.GRANADA, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ciber de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biosanitaria de Granada, ibs.GRANADA, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biosanitaria de Granada, ibs.GRANADA, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ciber de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gut Microbes</MedlineTA><NlmUniqueID>101495343</NlmUniqueID><ISSNLinking>1949-0976</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004043">Dietary Fiber</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000084922">Resistant Starch</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004043" MajorTopicYN="N">Dietary Fiber</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000084922" MajorTopicYN="N">Resistant Starch</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hypertension</Keyword><Keyword MajorTopicYN="N">endothelial dysfunction</Keyword><Keyword MajorTopicYN="N">fibers</Keyword><Keyword MajorTopicYN="N">gut dysbiosis</Keyword><Keyword MajorTopicYN="N">immune system</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>24</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>24</Day><Hour>7</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37615336</ArticleId><ArticleId IdType="pmc">PMC10453983</ArticleId><ArticleId IdType="doi">10.1080/19490976.2023.2247053</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Frosteg&#xe5;rd J. Systemic lupus erythematosus and cardiovascular disease. J Intern Med. 2023;293(1):48&#x2013;25. doi:10.1111/joim.13557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13557</ArticleId><ArticleId IdType="pmc">PMC10087345</ArticleId><ArticleId IdType="pubmed">35982610</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Herz A, Ensworth S, Shojania K, Esdaile JM. Cardiovascular risk factor screening in systemic lupus erythematosus. J Rheumatol. 2003;30:493&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pubmed">12610807</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf VL, Ryan MJ. Autoimmune disease-associated hypertension. Curr Hypertens Rep. 2019;21(1):10. doi:10.1007/s11906-019-0914-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-019-0914-2</ArticleId><ArticleId IdType="pmc">PMC6394456</ArticleId><ArticleId IdType="pubmed">30712132</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xf6;rstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 2017;120(4):713&#x2013;735. doi:10.1161/CIRCRESAHA.116.309326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.309326</ArticleId><ArticleId IdType="pubmed">28209797</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Guzm&#xe1;n M, Jim&#xe9;nez R, Romero M, S&#xe1;nchez M, Zarzuelo MJ, G&#xf3;mez-Morales M, O&#x2019;Valle F, L&#xf3;pez-Farr&#xe9; AJ, Algieri F, G&#xe1;lvez J, et al. Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus. Hypertension. 2014;64(2):330&#x2013;337. doi:10.1161/HYPERTENSIONAHA.114.03587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.114.03587</ArticleId><ArticleId IdType="pubmed">24842914</ArticleId></ArticleIdList></Reference><Reference><Citation>Hevia A, Milani C, L&#xf3;pez P, Cuervo A, Arboleya S, Duranti S, Turroni F, Gonz&#xe1;lez S, Su&#xe1;rez A, Gueimonde M, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. MBio. 2014;5(5). doi:10.1128/mBio.01548-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01548-14</ArticleId><ArticleId IdType="pmc">PMC4196225</ArticleId><ArticleId IdType="pubmed">25271284</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez P, S&#xe1;nchez B, Margolles A, Su&#xe1;rez A. Intestinal dysbiosis in systemic lupus erythematosus: cause or consequence? Curr Opin Rheumatol. 2016;28(5):515&#x2013;522. doi:10.1097/BOR.0000000000000309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000309</ArticleId><ArticleId IdType="pubmed">27466725</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Xu X, Li M, Cai J, Wei Q, Niu H. Gut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus. Mol Med. 2019;25(1):35. doi:10.1186/s10020-019-0102-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-019-0102-5</ArticleId><ArticleId IdType="pmc">PMC6676588</ArticleId><ArticleId IdType="pubmed">31370803</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo XM, Edwards MR, Mu Q, Yu Y, Vieson MD, Reilly CM, Ahmed SA, Bankole AA, McBain AJ. Gut microbiota in human systemic lupus erythematosus and a mouse model of lupus. Appl Environ Microbiol. 2018;84(4):84. doi:10.1128/AEM.02288-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02288-17</ArticleId><ArticleId IdType="pmc">PMC5795066</ArticleId><ArticleId IdType="pubmed">29196292</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Liao X, Sparks JB, Luo XM, Schloss PD. Dynamics of gut microbiota in autoimmune lupus. Appl Environ Microbiol. 2014;80(24):7551&#x2013;7560. doi:10.1128/AEM.02676-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02676-14</ArticleId><ArticleId IdType="pmc">PMC4249226</ArticleId><ArticleId IdType="pubmed">25261516</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Q, Tavella VJ, Kirby JL, Cecere TE, Chung M, Lee J, Li S, Ahmed SA, Eden K, Allen IC, et al. Antibiotics ameliorate lupus-like symptoms in mice. Sci Rep. 2017;7(1):1&#x2013;14. doi:10.1038/s41598-017-14223-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14223-0</ArticleId><ArticleId IdType="pmc">PMC5651817</ArticleId><ArticleId IdType="pubmed">29057975</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Q, Zhang H, Liao X, Lin K, Liu H, Edwards MR, Ahmed SA, Yuan R, Li L, Cecere TE, et al. Control of lupus nephritis by changes of gut microbiota. Microbiome. 2017;5(1):73. doi:10.1186/s40168-017-0300-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0300-8</ArticleId><ArticleId IdType="pmc">PMC5505136</ArticleId><ArticleId IdType="pubmed">28697806</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz-Agranov N, Zandman-Goddard G. The microbiome and systemic lupus erythematosus. Immunol Res. 2017;65(2):432&#x2013;437. doi:10.1007/s12026-017-8906-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-017-8906-2</ArticleId><ArticleId IdType="pubmed">28233089</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, Costa FRC, Tiniakou E, Greiling T, Ruff W, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Sci. 2018;359(6380):1156&#x2013;1161. doi:10.1126/science.aar7201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aar7201</ArticleId><ArticleId IdType="pmc">PMC5959731</ArticleId><ArticleId IdType="pubmed">29590047</ArticleId></ArticleIdList></Reference><Reference><Citation>Zegarra-Ruiz DF, El Beidaq A, In AJ, Greiling TM, Dehner C, Kriegel MA, Lubrano M, Ricco D, Zegarra-Ruiz DF, El Beidaq A, et al. A diet-sensitive commensal lactobacillus strain article a diet-Sensitive commensal Lactobacillus strainmediates TLR7-dependent systemic autoimmunity. Cell Host &amp; Microbe. 2019;25(1):113&#x2013;127.e6. doi:10.1016/j.chom.2018.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.11.009</ArticleId><ArticleId IdType="pmc">PMC6377154</ArticleId><ArticleId IdType="pubmed">30581114</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):14. doi:10.1186/s40168-016-0222-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-016-0222-x</ArticleId><ArticleId IdType="pmc">PMC5286796</ArticleId><ArticleId IdType="pubmed">28143587</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Visitaci&#xf3;n N, Robles-Vera I, Toral M, G&#xf3;mez-Guzm&#xe1;n M, S&#xe1;nchez M, Mole&#xf3;n J, Gonz&#xe1;lez-Correa C, Mart&#xed;n-Morales N, O&#x2019;Valle F, Jim&#xe9;nez R, et al. Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus. Br J Pharmacol. 2021;178(18):3708&#x2013;3729. doi:10.1111/bph.15512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15512</ArticleId><ArticleId IdType="pubmed">33931880</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Visitaci&#xf3;n N, Robles-Vera I, Mole&#xf3;n J, Gonz&#xe1;lez-Correa C, Aguilera-S&#xe1;nchez N, Toral M, G&#xf3;mez-Guzm&#xe1;n M, S&#xe1;nchez M, Jim&#xe9;nez R, Martin-Morales N, et al. Gut microbiota has a crucial role in the development of hypertension and vascular dysfunction in Toll-like receptor 7-driven lupus autoimmunity. Antioxidants (Basel, Switzerland). 2021;10(9):1426. doi:10.3390/antiox10091426.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10091426</ArticleId><ArticleId IdType="pmc">PMC8472682</ArticleId><ArticleId IdType="pubmed">34573058</ArticleId></ArticleIdList></Reference><Reference><Citation>Karbach SH, Sch&#xf6;nfelder T, Brand&#xe3;o I, Wilms E, H&#xf6;rmann N, J&#xe4;ckel S, Sch&#xfc;ler R, Finger S, Knorr M, Lagrange J, et al. Gut microbiota Promote angiotensin II&#x2013;induced arterial hypertension and vascular dysfunction. J Am Heart Assoc. 2016;5(9):e003698. doi:10.1161/JAHA.116.003698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.003698</ArticleId><ArticleId IdType="pmc">PMC5079031</ArticleId><ArticleId IdType="pubmed">27577581</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilck N, Matus MG, Kearney SM, Olesen SW, Forslund K, Bartolomaeus H, Haase S, M&#xe4;hler A, Balogh A, Mark&#xf3; L, et al. Salt-responsive gut commensal modulates TH17 axis and disease. Nature. 2017;551(7682):585&#x2013;589. doi:10.1038/nature24628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24628</ArticleId><ArticleId IdType="pmc">PMC6070150</ArticleId><ArticleId IdType="pubmed">29143823</ArticleId></ArticleIdList></Reference><Reference><Citation>Toral M, Robles-Vera I, Romero M, de la Visitacion N, Sanchez M, O&#x2019;Valle F, Rodriguez-Nogales A, Galvez J, Duarte J, Jimenez R. Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus. FASEB J Off Publ Fed Am Soc Exp Biol. 2019;33(9):10005&#x2013;10018. doi:10.1096/fj.201900545RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201900545RR</ArticleId><ArticleId IdType="pubmed">31173526</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Visitaci&#xf3;n N, Robles-Vera I, Toral M, O&#x2019;Valle F, Moleon J, G&#xf3;mez-Guzm&#xe1;n M, Romero M, Duarte M, S&#xe1;nchez M, Jim&#xe9;nez R, et al. Lactobacillus fermentum CECT5716 prevents renal damage in the NZBWF1 mouse model of systemic lupus erythematosus. Food Funct. 2020;11(6):5266&#x2013;5274. doi:10.1039/D0FO00578A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D0FO00578A</ArticleId><ArticleId IdType="pubmed">32458936</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkan A-C, Anania C, Gustafsson T, Jogestrand T, Hafstr&#xf6;m I, Frosteg&#xe5;rd J. Diet and fatty acid pattern among patients with SLE: associations with disease activity, blood lipids and atherosclerosis. Lupus. 2012;21(13):1405&#x2013;1411. doi:10.1177/0961203312458471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203312458471</ArticleId><ArticleId IdType="pubmed">22930204</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xe4;fer A-L, Eichhorst A, Hentze C, Kraemer AN, Amend A, Sprenger DTL, Fluhr C, Finzel S, Daniel C, Salzer U, et al. Low dietary fiber intake links development of obesity and lupus pathogenesis. Front Immunol. 2021;12:696810. doi:10.3389/fimmu.2021.696810.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.696810</ArticleId><ArticleId IdType="pmc">PMC8320762</ArticleId><ArticleId IdType="pubmed">34335609</ArticleId></ArticleIdList></Reference><Reference><Citation>Minami Y, Hirabayashi Y, Nagata C, Ishii T, Harigae H, Sasaki T. Intakes of vitamin B6 and dietary fiber and clinical course of systemic lupus erythematosus: a prospective study of Japanese female patients. J Epidemiol. 2011;21(4):246&#x2013;254. doi:10.2188/jea.JE20100157.</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20100157</ArticleId><ArticleId IdType="pmc">PMC3899416</ArticleId><ArticleId IdType="pubmed">21515941</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye DM, Shihata WA, Jama HA, Tsyganov K, Ziemann M, Kiriazis H, Horlock D, Vijay A, Giam B, Vinh A, et al. Deficiency of prebiotic fiber and Insufficient Signaling through gut metabolite-sensing receptors leads to cardiovascular disease. Circulation. 2020;141(17):1393&#x2013;1403. doi:10.1161/CIRCULATIONAHA.119.043081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.043081</ArticleId><ArticleId IdType="pubmed">32093510</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques FZ, Nelson E, Chu P-Y, Horlock D, Fiedler A, Ziemann M, Tan JK, Kuruppu S, Rajapakse NW, El-Osta A, et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation. 2017;135(10):964&#x2013;977. doi:10.1161/CIRCULATIONAHA.116.024545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.024545</ArticleId><ArticleId IdType="pubmed">27927713</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zhu Q, Lu A, Liu X, Zhang L, Xu C, Liu X, Li H, Yang T. Sodium butyrate suppresses angiotensin II-induced hypertension by inhibition of renal (pro)renin receptor and intrarenal renin&#x2013;angiotensin system. J Hypertens. 2017;35(9):1899&#x2013;1908. doi:10.1097/HJH.0000000000001378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000001378</ArticleId><ArticleId IdType="pubmed">28509726</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Goel R, Kumar A, Qi Y, Lobaton G, Hosaka K, Mohammed M, Handberg EM, Richards EM, Pepine CJ, et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin Sci (Lond). 2018;132(6):701&#x2013;718. doi:10.1042/CS20180087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180087</ArticleId><ArticleId IdType="pmc">PMC5955695</ArticleId><ArticleId IdType="pubmed">29507058</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartolomaeus H, Balogh A, Yakoub M, Homann S, Mark&#xf3; L, H&#xf6;ges S, Tsvetkov D, Krannich A, Wundersitz S, Avery EG, et al. Short-chain fatty acid propionate protects from hypertensive cardiovascular damage. Circulation. 2019;139(11):1407&#x2013;1421. doi:10.1161/CIRCULATIONAHA.118.036652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.036652</ArticleId><ArticleId IdType="pmc">PMC6416008</ArticleId><ArticleId IdType="pubmed">30586752</ArticleId></ArticleIdList></Reference><Reference><Citation>Robles-Vera I, de la Visitaci&#xf3;n N, Toral M, S&#xe1;nchez M, Romero M, G&#xf3;mez-Guzm&#xe1;n M, Yang T, Izquierdo-Garc&#xed;a JL, Guerra-Hern&#xe1;ndez E, Ruiz-Cabello J, et al. Probiotic Bifidobacterium breve prevents DOCA-salt hypertension. FASEB J Off Publ Fed Am Soc Exp Biol. 2020;34(10):13626&#x2013;13640. doi:10.1096/fj.202001532R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202001532R</ArticleId><ArticleId IdType="pubmed">32780919</ArticleId></ArticleIdList></Reference><Reference><Citation>Robles-Vera I, Toral M, de la Visitaci&#xf3;n N, S&#xe1;nchez M, G&#xf3;mez-Guzm&#xe1;n M, Romero M, Yang T, Izquierdo-Garcia JL, Jim&#xe9;nez R, Ruiz-Cabello J, et al. Probiotics prevent dysbiosis and the rise in blood pressure in genetic hypertension: Role of Short-chain fatty acids. Mol Nutr Food Res. 2020;64(6):e1900616. doi:10.1002/mnfr.201900616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201900616</ArticleId><ArticleId IdType="pubmed">31953983</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan MJ, McLemore GRJ. Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus. Am J Physiol Regul Integr Comp Physiol. 2007;292(2):R736&#x2013;42. doi:10.1152/ajpregu.00168.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00168.2006</ArticleId><ArticleId IdType="pubmed">16971374</ArticleId></ArticleIdList></Reference><Reference><Citation>Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, Fauad-Tarazi F, Horan MJ, Marcus M, Massie B. The heart in hypertension. N Engl J Med. 1992;327(14):998&#x2013;1008. doi:10.1056/NEJM199210013271406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199210013271406</ArticleId><ArticleId IdType="pubmed">1518549</ArticleId></ArticleIdList></Reference><Reference><Citation>Wofsy D, Chiang NY, Greenspan JS, Ermak TH. Treatment of murine lupus with monoclonal antibody to L3T4. I. Effects on the distribution and function of lymphocyte subsets and on the histopathology of autoimmune disease. J Autoimmun. 1988;1(5):415&#x2013;431. doi:10.1016/0896-8411(88)90065-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-8411(88)90065-0</ArticleId><ArticleId IdType="pubmed">3267085</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorraji SE, Kanapathippillai P, Hovd A-M, Stenersr&#xf8;d MR, Horvei KD, Ursvik A, Figenschau SL, Thiyagarajan D, Fenton CG, Pedersen HL, et al. Kidney Tertiary lymphoid Structures in lupus nephritis develop into large interconnected networks and resemble lymph nodes in gene signature. Am J Pathol. 2020;190(11):2203&#x2013;2225. doi:10.1016/j.ajpath.2020.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2020.07.015</ArticleId><ArticleId IdType="pubmed">32818496</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 1991;9(1):243&#x2013;269. doi:10.1146/annurev.iy.09.040191.001331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.iy.09.040191.001331</ArticleId><ArticleId IdType="pubmed">1910678</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28(10):1221&#x2013;1227. doi:10.1136/gut.28.10.1221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.28.10.1221</ArticleId><ArticleId IdType="pmc">PMC1433442</ArticleId><ArticleId IdType="pubmed">3678950</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritzhaupt A, Wood IS, Ellis A, Hosie KB, Shirazi-Beechey SP. Identification and characterization of a monocarboxylate transporter (MCT1) in pig and human colon: its potential to transport L-lactate as well as butyrate. J Physiol. 1998;513(3):719&#x2013;732. doi:10.1111/j.1469-7793.1998.719ba.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.1998.719ba.x</ArticleId><ArticleId IdType="pmc">PMC2231331</ArticleId><ArticleId IdType="pubmed">9824713</ArticleId></ArticleIdList></Reference><Reference><Citation>Parada Venegas D, De la Fuente MK, Landskron G, Gonz&#xe1;lez MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA. Corrigendum: Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:1486. doi:10.3389/fimmu.2019.01486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01486</ArticleId><ArticleId IdType="pmc">PMC6611342</ArticleId><ArticleId IdType="pubmed">31316522</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J-H, Kotani T, Konno T, Setiawan J, Kitamura Y, Imada S, Usui Y, Hatano N, Shinohara M, Saito Y, et al. Promotion of intestinal epithelial cell turnover by commensal bacteria: Role of Short-chain fatty acids. PLoS One. 2016;11(5):e0156334. doi:10.1371/journal.pone.0156334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0156334</ArticleId><ArticleId IdType="pmc">PMC4883796</ArticleId><ArticleId IdType="pubmed">27232601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly CJ, Colgan SP. Breathless in the gut: Implications of Luminal O2 for microbial pathogenicity. Cell Host &amp; Microbe. 2016;19(4):427&#x2013;428. doi:10.1016/j.chom.2016.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.03.014</ArticleId><ArticleId IdType="pmc">PMC5256639</ArticleId><ArticleId IdType="pubmed">27078062</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Bosch C, Boorman E, Zunszain PA, Mann GE. Short-chain fatty acids as modulators of redox signaling in health and disease. Redox Biol. 2021;47:102165. doi:10.1016/j.redox.2021.102165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.102165</ArticleId><ArticleId IdType="pmc">PMC8577496</ArticleId><ArticleId IdType="pubmed">34662811</ArticleId></ArticleIdList></Reference><Reference><Citation>Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity. Cytokine. 2015;72(2):146&#x2013;153. doi:10.1016/j.cyto.2014.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2014.12.027</ArticleId><ArticleId IdType="pubmed">25647269</ArticleId></ArticleIdList></Reference><Reference><Citation>Dar O, Salaman MR, Seifert MH, Isenberg DA. B lymphocyte activation in systemic lupus erythematosus: spontaneous production of IgG antibodies to DNA and environmental antigens in cultures of blood mononuclear cells. Clin Exp Immunol. 1988;73:430&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1541767</ArticleId><ArticleId IdType="pubmed">3264772</ArticleId></ArticleIdList></Reference><Reference><Citation>Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, Vyas JM, Boes M, Ploegh HL, Fox JG, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Sci. 2005;307(5707):254&#x2013;258. doi:10.1126/science.1102901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1102901</ArticleId><ArticleId IdType="pubmed">15653504</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinh A, Chen W, Blinder Y, Weiss D, Taylor WR, Goronzy JJ, Weyand CM, Harrison DG, Guzik TJ. Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation. 2010;122(24):2529&#x2013;2537. doi:10.1161/CIRCULATIONAHA.109.930446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.930446</ArticleId><ArticleId IdType="pmc">PMC3064430</ArticleId><ArticleId IdType="pubmed">21126972</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora JR, von Andrian UH. Differentiation and homing of IgA-secreting cells. Mucosal Immunol. 2008;1(2):96&#x2013;109. doi:10.1038/mi.2007.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2007.14</ArticleId><ArticleId IdType="pubmed">19079167</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol. 2010;40(7):1830&#x2013;1835. doi:10.1002/eji.201040391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201040391</ArticleId><ArticleId IdType="pubmed">20583029</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Su W, Wan T, Yu J, Zhu W, Tang F, Liu G, Olsen N, Liang D, Zheng SG. Sodium butyrate regulates Th17/Treg cell balance to ameliorate uveitis via the Nrf2/HO-1 pathway. Biochem Pharmacol. 2017;142:111&#x2013;119. doi:10.1016/j.bcp.2017.06.136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2017.06.136</ArticleId><ArticleId IdType="pubmed">28684304</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKay CE, Shaifta Y, Snetkov VV, Francois AA, Ward JPT, Knock GA. ROS-dependent activation of RhoA/Rho-kinase in pulmonary artery: Role of src-family kinases and ARHGEF1. Free Radic Biol Med. 2017;110:316&#x2013;331. doi:10.1016/j.freeradbiomed.2017.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2017.06.022</ArticleId><ArticleId IdType="pmc">PMC5542024</ArticleId><ArticleId IdType="pubmed">28673614</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang CF, Liu JT, Wang Y, Xu A, Vanhoutte PM. Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4. Arterioscler Thromb Vasc Biol. 2013;33(4):777&#x2013;784. doi:10.1161/ATVBAHA.112.301087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.112.301087</ArticleId><ArticleId IdType="pubmed">23413427</ArticleId></ArticleIdList></Reference><Reference><Citation>Robles-Vera I, Toral M, de la Visitaci&#xf3;n N, Aguilera-S&#xe1;nchez N, Redondo JM, Duarte J. Protective effects of Short-chain fatty acids on endothelial dysfunction induced by angiotensin II. Front Physiol. 2020;11:277. doi:10.3389/fphys.2020.00277.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00277</ArticleId><ArticleId IdType="pmc">PMC7176911</ArticleId><ArticleId IdType="pubmed">32372967</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor EB, Ryan MJ. Understanding mechanisms of hypertension in systemic lupus erythematosus. Ther Adv Cardiovasc Dis. 2016;11(1):20&#x2013;32. doi:10.1177/1753944716637807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753944716637807</ArticleId><ArticleId IdType="pmc">PMC5065379</ArticleId><ArticleId IdType="pubmed">26985016</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Visitaci&#xf3;n N, Robles-Vera I, Toral M, Duarte J. Protective effects of probiotic consumption in cardiovascular disease in systemic lupus erythematosus. Nutrients. 2019;11:2676. doi:10.3390/nu11112676.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11112676</ArticleId><ArticleId IdType="pmc">PMC6893408</ArticleId><ArticleId IdType="pubmed">31694260</ArticleId></ArticleIdList></Reference><Reference><Citation>Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004;54(5):1469&#x2013;1476. doi:10.1099/ijs.0.02873-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/ijs.0.02873-0</ArticleId><ArticleId IdType="pubmed">15388697</ArticleId></ArticleIdList></Reference><Reference><Citation>Catry E, Bindels LB, Tailleux A, Lestavel S, Neyrinck AM, Goossens J-F, Lobysheva I, Plovier H, Essaghir A, Demoulin J-B, et al. Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction. Gut. 2018;67(2):271&#x2013;283. doi:10.1136/gutjnl-2016-313316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2016-313316</ArticleId><ArticleId IdType="pmc">PMC5868295</ArticleId><ArticleId IdType="pubmed">28377388</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Lin S, Vanhoutte PM, Woo CW, Xu A. Akkermansia muciniphila protects against atherosclerosis by Preventing metabolic endotoxemia-induced inflammation in Apoe &#x2212;/&#x2212; mice. Circulation. 2016;133(24):2434&#x2013;2446. doi:10.1161/CIRCULATIONAHA.115.019645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.019645</ArticleId><ArticleId IdType="pubmed">27143680</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel K, Haase H, Wallukat G, Derer W, Bartel S, Homuth V, Herse F, Hubner N, Schulz H, Janczikowski M, et al. Potential relevance of &#x3b1;1-adrenergic receptor autoantibodies in Refractory hypertension. PLoS One. 2008;3(11):e3742. doi:10.1371/journal.pone.0003742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0003742</ArticleId><ArticleId IdType="pmc">PMC2580028</ArticleId><ArticleId IdType="pubmed">19011682</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero M, Toral M, Robles-Vera I, Sanchez M, Jimenez R, O&#x2019;Valle F, Rodriguez-Nogales A, Perez-Vizcaino F, Galvez J, Duarte J. Activation of peroxisome proliferator activator receptor &#x3b2;/&#x3b4; Improves endothelial dysfunction and protects kidney in murine lupus. Hypertension. 2017;69(4):641&#x2013;650. doi:10.1161/HYPERTENSIONAHA.116.08655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.116.08655</ArticleId><ArticleId IdType="pubmed">28242713</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley VR, Wuthrich RP. Cytokines in the pathogenesis of systemic lupus erythematosus. Semin Nephrol. 1999;19:57&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">9952281</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan MJ. An update on immune system activation in the pathogenesis of hypertension. Hypertension. 2013;62(2):226&#x2013;230. doi:10.1161/HYPERTENSIONAHA.113.00603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.113.00603</ArticleId><ArticleId IdType="pmc">PMC4365420</ArticleId><ArticleId IdType="pubmed">23734005</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H, Chiasson VL, Chatterjee P, Kopriva SE, Young KJ, Mitchell BM. Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension. Cardiovasc Res. 2013;97(4):696&#x2013;704. doi:10.1093/cvr/cvs422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvs422</ArticleId><ArticleId IdType="pmc">PMC3583258</ArticleId><ArticleId IdType="pubmed">23263331</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrowski E, Bender B, Huppert J, White R, Luhmann HJ, Kuhlmann CRW. Pro-inflammatory effects of interleukin-17A on vascular smooth muscle cells involve NAD(P)H- oxidase derived reactive oxygen species. J Vasc Res. 2011;48(1):52&#x2013;58. doi:10.1159/000317400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000317400</ArticleId><ArticleId IdType="pubmed">20606471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward MM, Studenski S. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med. 1992;152(10):2082&#x2013;2088. doi:10.1001/archinte.1992.00400220098017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1992.00400220098017</ArticleId><ArticleId IdType="pubmed">1417382</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrin J, Rozman B, Dolenc P, Logar D, Bozic B, Vizjak A, Ferluga D, Jezersek P. The dissociation of arterial hypertension and lupus glomerulonephritis in systemic lupus erythematosus. Blood Press. 1993;2(2):108&#x2013;112. doi:10.3109/08037059309077537.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08037059309077537</ArticleId><ArticleId IdType="pubmed">8180722</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaharir SS, Mustafar R, Mohd R, Mohd Said MS, Gafor HA. Persistent hypertension in lupus nephritis and the associated risk factors. Clin Rheumatol. 2015;34(1):93&#x2013;97. doi:10.1007/s10067-014-2802-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-014-2802-0</ArticleId><ArticleId IdType="pubmed">25373448</ArticleId></ArticleIdList></Reference><Reference><Citation>Beale AL, Kaye DM, Marques FZ. The role of the gut microbiome in sex differences in arterial pressure. Biol Sex Differ. 2019;10(1):22. doi:10.1186/s13293-019-0236-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-019-0236-8</ArticleId><ArticleId IdType="pmc">PMC6485140</ArticleId><ArticleId IdType="pubmed">31023366</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques FZ, Jama HA, Tsyganov K, Gill PA, Rhys-Jones D, Muralitharan RR, Muir J, Holmes A, Mackay CR. Guidelines for transparency on gut microbiome studies in essential and experimental hypertension. Hypertens (Dallas, Tex 1979). 2019;74(6):1279&#x2013;1293. doi:10.1161/HYPERTENSIONAHA.119.13079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.119.13079</ArticleId><ArticleId IdType="pubmed">31679421</ArticleId></ArticleIdList></Reference><Reference><Citation>Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. Br J Pharmacol. 2020;177(16):3617&#x2013;3624. doi:10.1111/bph.15193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15193</ArticleId><ArticleId IdType="pmc">PMC7393194</ArticleId><ArticleId IdType="pubmed">32662519</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill GS, Delahousse M, Nochy D, Bari&#xe9;ty J. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis. Kidney Int. 2005;68(5):2288&#x2013;2297. doi:10.1111/j.1523-1755.2005.00688.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2005.00688.x</ArticleId><ArticleId IdType="pubmed">16221231</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, Li L. Dansylhydrazine isotope labeling LC-MS for comprehensive carboxylic acid submetabolome profiling. Anal Chem. 2018;90(22):13514&#x2013;13522. doi:10.1021/acs.analchem.8b03435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.8b03435</ArticleId><ArticleId IdType="pubmed">30339755</ArticleId></ArticleIdList></Reference><Reference><Citation>Toral M, Romero M, Rodriguez-Nogales A, Jimenez R, Robles-Vera I, Algieri F, Chueca-Porcuna N, Sanchez M, de la Visitacion N, Olivares M, et al. Lactobacillus fermentum improves tacrolimus-induced hypertension by restoring vascular redox state and improving eNOS Coupling. Mol Nutr Food Res. 2018;62(14):e1800033. doi:10.1002/mnfr.201800033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201800033</ArticleId><ArticleId IdType="pubmed">29851248</ArticleId></ArticleIdList></Reference><Reference><Citation>Dole VS, Henderson KS, Fister RD, Pietrowski MT, Maldonado G, Clifford CB. Pathogenicity and genetic variation of 3 strains of Corynebacterium bovis in immunodeficient mice. J Am Assoc Lab Anim Sci. 2013;52:458&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3725931</ArticleId><ArticleId IdType="pubmed">23849444</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, Fierer N, Knight R. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci USA. 2011;108(supplement_1):4516&#x2013;4522. doi:10.1073/pnas.1000080107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1000080107</ArticleId><ArticleId IdType="pmc">PMC3063599</ArticleId><ArticleId IdType="pubmed">20534432</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H-W, Li D-F, Tam NFY, Jiang X-T, Zhang H, Sheng H-F, Qin J, Liu X, Zou F. BIPES, a cost-effective high-throughput method for assessing microbial diversity. ISME J. 2011;5(4):741&#x2013;749. doi:10.1038/ismej.2010.160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ismej.2010.160</ArticleId><ArticleId IdType="pmc">PMC3105743</ArticleId><ArticleId IdType="pubmed">20962877</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Liu H-Y, Zhou H, Zhan Q, Lai W, Zeng Q, Ren H, Xu D. Moderate-intensity exercise affects gut microbiome composition and influences cardiac function in myocardial infarction mice. Front Microbiol. 2017;8:1687. doi:10.3389/fmicb.2017.01687.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.01687</ArticleId><ArticleId IdType="pmc">PMC5585143</ArticleId><ArticleId IdType="pubmed">28919891</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar RC, Flyvbjerg H. Error filtering, pair assembly and error correction for next-generation sequencing reads. Bioinformatics. 2015;31(21):3476&#x2013;3482. doi:10.1093/bioinformatics/btv401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btv401</ArticleId><ArticleId IdType="pubmed">26139637</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Q, Li D, He Y, Li Y, Yang Z, Zhao X, Liu Y, Wang Y, Sun J, Feng X, et al. Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities. Sci Rep. 2019;9(1):13424. doi:10.1038/s41598-019-49462-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-49462-w</ArticleId><ArticleId IdType="pmc">PMC6748942</ArticleId><ArticleId IdType="pubmed">31530820</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia WJ, Xu ML, Yu XJ, Du MM, Li XH, Yang T, Li L, Li Y, Kang KB, Su Q, et al. Antihypertensive effects of exercise involve reshaping of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rat. Gut Microbes. 2021;13(1):1&#x2013;24. doi:10.1080/19490976.2020.1854642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2020.1854642</ArticleId><ArticleId IdType="pmc">PMC7781639</ArticleId><ArticleId IdType="pubmed">33382364</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>